Friday - April 4, 2025
Haynes & Boone Represents RedHill in Global Licensing Agreement With Hyloris
February 28, 2025
DALLAS, Texas, Feb. 28 -- Haynes and Boone, a law firm, issued the following news release:

* * *

Haynes Boone Represents RedHill in Global Licensing Agreement with Hyloris

A cross-practice Haynes Boone team represented RedHill Biopharma Ltd. (NASDAQ: RDHL) in negotiating an exclusive worldwide development and commercialization licensing agreement, excluding North America, for its RHB-102 drug candidate, securing potential payments of up to $60 million plus . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products